143 related articles for article (PubMed ID: 3046680)
1. Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma.
Tobinai K; Minato K; Ohtsu T; Mukai K; Kagami Y; Miwa M; Watanabe S; Shimoyama M
Blood; 1988 Sep; 72(3):1000-6. PubMed ID: 3046680
[TBL] [Abstract][Full Text] [Related]
2. Immunoblastic lymphadenopathy, angioimmunoblastic lymphadenopathy, and IBL-like T-cell lymphoma. A spectrum of T-cell neoplasia.
Watanabe S; Sato Y; Shimoyama M; Minato K; Shimosato Y
Cancer; 1986 Nov; 58(10):2224-32. PubMed ID: 3093047
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.
Brown HA; Macon WR; Kurtin PJ; Gibson LE
J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382
[TBL] [Abstract][Full Text] [Related]
4. Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.
Weiss LM; Strickler JG; Dorfman RF; Horning SJ; Warnke RA; Sklar J
Am J Pathol; 1986 Mar; 122(3):392-7. PubMed ID: 3082212
[TBL] [Abstract][Full Text] [Related]
5. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
[TBL] [Abstract][Full Text] [Related]
6. Immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma in a child.
Nakazono S; Kitahara T; Takezaki T; Kawakami K; Hasui K; Satoh E; Tokunaga M
Acta Paediatr Jpn; 1991 Jun; 33(3):398-407. PubMed ID: 1785338
[TBL] [Abstract][Full Text] [Related]
7. Immunoblastic lymphadenopathy-like T-cell lymphoma with multiple cutaneous and visceral involvements.
Nakamine H; Nishino E; Takenaka T; Maeda J; Kushigami M; Ikeda A; Nishioka S; Yataka I; Hanaoka M
Acta Pathol Jpn; 1986 Nov; 36(11):1757-68. PubMed ID: 3492859
[TBL] [Abstract][Full Text] [Related]
8. [Recent advances in clinical research on T-cell lymphoma].
Tobinai K; Shimoyama M
Rinsho Ketsueki; 1990 May; 31(5):564-8. PubMed ID: 2395207
[TBL] [Abstract][Full Text] [Related]
9. Atypical lymphoplasmacytic and immunoblastic proliferation in lymph nodes of patients with autoimmune disease (autoimmune-disease-associated lymphadenopathy).
Koo CH; Nathwani BN; Winberg CD; Hill LR; Rappaport H
Medicine (Baltimore); 1984 Sep; 63(5):274-90. PubMed ID: 6381957
[TBL] [Abstract][Full Text] [Related]
10. Clonal T cell population in angioimmunoblastic lymphadenopathy and related lesions.
Suzuki H; Namikawa R; Ueda R; Obata Y; Suchi T; Kikuchi M; Ota K; Takahashi T
Jpn J Cancer Res; 1987 Jul; 78(7):712-20. PubMed ID: 3114197
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and therapeutic aspects of angioimmunoblastic lymphadenopathy-related lesions.
Ohsaka A; Saito K; Sakai T; Mori S; Kobayashi Y; Amemiya Y; Sakamoto S; Miura Y
Cancer; 1992 Mar; 69(5):1259-67. PubMed ID: 1739925
[TBL] [Abstract][Full Text] [Related]
12. Immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma: clinico-pathologic, immunophenotypic and immunogenotypic analyses.
Tobinai K; Minato K; Ohtsu T; Mukai K; Kagami Y; Miwa M; Watanabe S; Shimoyama M
Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1668-76. PubMed ID: 2965847
[No Abstract] [Full Text] [Related]
13. Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy.
Feller AC; Griesser H; Schilling CV; Wacker HH; Dallenbach F; Bartels H; Kuse R; Mak TW; Lennert K
Am J Pathol; 1988 Dec; 133(3):549-56. PubMed ID: 2849301
[TBL] [Abstract][Full Text] [Related]
14. Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy.
Smith JL; Hodges E; Quin CT; McCarthy KP; Wright DH
Am J Pathol; 2000 Feb; 156(2):661-9. PubMed ID: 10666395
[TBL] [Abstract][Full Text] [Related]
15. Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment.
Sallah S; Gagnon GA
Acta Haematol; 1998; 99(2):57-64. PubMed ID: 9554450
[TBL] [Abstract][Full Text] [Related]
16. Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive "angioimmunoblastic lymphadenopathy with dysproteinemia-type" features.
Kaneko Y; Maseki N; Sakurai M; Takayama S; Nanba K; Kikuchi M; Frizzera G
Blood; 1988 Aug; 72(2):413-21. PubMed ID: 3261178
[TBL] [Abstract][Full Text] [Related]
17. Angioimmunoblastic lymphadenopathy with dysproteinemia following doxycycline administration.
Batinac T; Zamolo G; Jonjić N; Gruber F; Nacinović A; Seili-Bekafigo I; Coklo M
Tumori; 2003; 89(1):91-5. PubMed ID: 12729371
[TBL] [Abstract][Full Text] [Related]
18. [Biclonal gammopathy in a patient with immunoblastic lymphadenopathy like T cell lymphoma].
Murakami M; Sugiura K
Rinsho Ketsueki; 1989 Jan; 30(1):116-21. PubMed ID: 2497263
[TBL] [Abstract][Full Text] [Related]
19. Angioimmunoblastic lymphadenopathy and related disorders: a retrospective look in search of definitions.
Frizzera G; Kaneko Y; Sakurai M
Leukemia; 1989 Jan; 3(1):1-5. PubMed ID: 2642571
[TBL] [Abstract][Full Text] [Related]
20. B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus.
Abruzzo LV; Schmidt K; Weiss LM; Jaffe ES; Medeiros LJ; Sander CA; Raffeld M
Blood; 1993 Jul; 82(1):241-6. PubMed ID: 8391875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
